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Abstract 
Objective We aimed to evaluate the effects on depression scores of a lifestyle-focused cardiac 
support program delivered via mobile-phone text messaging among patients with coronary heart 
disease (CHD).  
 
Design Sub-study and secondary analysis of a parallel group, single-blind randomized controlled 
trial of patients with CHD 
 
Setting A tertiary hospital in Sydney, Australia  
 
Intervention The TEXT ME comprised 4 text messages per week for 6 months that provided 
education, motivation and support on diet, physical activity, general cardiac education and 
smoking, if relevant. The program did not have any specific mental health component.  
 
Outcomes  Depression scores at 6 months measured using the Patient Health Questionnaire-9 
(PHQ-9). Treatment effect across sub-groups was measured using log-binomial regression model 
for the binary outcome (depressed/not depressed, where depressed is any score of PHQ-9 ≥5) 
with treatment, subgroup and treatment by subgroup interaction as fixed effects.  
 
Results Depression scores at 6 months were lower in the intervention group compared to the 
control group, mean difference 1.9 (95% CI 1.5-2.4, p-value <0.0001). The frequency of mild or 
greater depressive symptoms (PHQ-9 scores ≥5) at 6 months was 21/333 (6.3%) in the 
intervention group and 86/350 (24.6%) in the control group (relative risk 0.26, 95% CI 0.16-0.40, 
p <0.001). This proportional reduction in depressive symptoms was similar across groups defined 
by age, sex, education, BMI, physical activity, current smoking, current drinking, and history of 
depression, diabetes, and hypertension. In particular, the rates of PHQ-9 ≥5 among people with a 
history of depression were 4/44 (9.1%) vs 29/62 (46.8%) in intervention vs control (RR 0.19, 95% 
CI 0.07 to 0.51, p<0.001), and were 17/289 (5.9%) vs 57/288 (19.8%) among others (RR 0.30, 
95% CI 0.18 to 0.50, p<0.001).  
 
Conclusions Among people with CHD a cardiac support program delivered via mobile-phone text 
messaging was associated with less symptoms of mild-to-moderate depression at 6 months in the 
treatment group compared to controls.  
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Trial Registration: Australian New Zealand Clinical Trials Registry Number (ANZCTRN): 
anzctr.org.au Identifier: ACTRN12611000161921 
 
Keywords: Text Message; Mobile Phones; Cardiovascular Diseases; Mental Health; Diabetes; 
Hypertension; Coronary Heart Diseases. 
 
Strengths and limitations of this study 
- The strength of this trial is the parallel group, prospective, randomized controlled design  
- The trial had a relatively large sample size 
- With respect to limitations, it is a single-centre study.  
- Depression was measured using the PHQ-9 tool, which is designed as a screening tool.   
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Introduction 
Depression is common among patients with chronic diseases including coronary heart disease 
(CHD) and often under-recognized and untreated.1 Comorbid depression affects daily function 
and is associated with substantial impairment in health-related quality of life and worse clinical 
outcomes in patients with CHD. 2-4 As well as the direct negative impact of depression on the 
wellbeing of patients and their carers, depression after myocardial infarction is associated with 
substantially increased risk of cardiovascular and all-cause mortality.5 Patients with depression 
and CHD need effective treatment and support for both conditions. Attendance at cardiac 
rehabilitation following a cardiac event decreases morbidity, mortality, depressive symptoms and 
improves quality of life. 6 7 Nevertheless, access to cardiac rehabilitation remains difficult, 
especially for those who are financially disadvantaged, part of an ethnic minority group, older or 
living far from health centres with limited access to transport.8 Also, research suggests some 
simple interventions delivered in the community/ primary care can improve mental health 
outcomes and integrating treatments into chronic disease management improves outcomes. 9 10 
Innovation is clearly needed to provide ongoing support for patients with cardiac and other 
chronic conditions, within limited healthcare resources.  
 
In recent years, mobile phone technologies such as text messaging interventions comprising health 
education and reminders have shown promise in improving healthcare service delivery,11 
increasing medication adherence, 12 and improving primary prevention of cardiovascular disease – 
for example improving glycaemic control among diabetes,13 and improving smoking quit rates.14 
With respect to mental health, previous trials have reported that automated text messaging offered 
a feasible and acceptable means of monitoring depression and has the potential to improve 
outcomes in patients with comorbid depression.15 16 A systematic review of 6 trials involving 577 
participants with mental health disorders (depression, alcohol dependence, schizophrenia and 
mood disorders) showed text messaging for health education, therapy goals and medication 
reminders interventions significantly improved several mental health related outcomes in 5 studies 
including depression and quality of life scores.17 However, most of these were pilot studies and 
little is known about the extent to which text messaging might reduce depressive symptoms in 
people with CHD. We conducted the Tobacco, Exercise and dieT MEssages (TEXT ME) 
randomized controlled clinical trial in patients with CHD that addressed multiple cardiovascular 
risk factors.18 The TEXT ME trial resulted in a modest improvement in LDL-C level and greater 
improvement in other cardiovascular disease risk factors including blood pressure, body mass 
index, physical activity and smoking among patient with CHD. 19 The objective of this secondary 
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and exploratory analysis of the TEXT ME study was to examine if the text message support 
program had an impact on depressive symptoms at 6 months.  
 
Methods 
Study design: The current analyses were a pre-specified secondary analysis of the TEXT ME trial 
18. In brief, TEXT ME was a parallel-design, single-blind, randomised controlled clinical trial 
enrolling 710 patients with CHD from a tertiary hospital in Sydney, Australia between September 
2011 and November 2013.19 The text messaging program and its development process are detailed 
elsewhere.19  
Participants: Potential participants were identified through screening daily admissions, coronary 
angiogram case lists, and cardiology outpatient clinic lists from a large tertiary care hospital which 
serves a diverse population in terms of ethnicity and socioeconomic status in the Western Sydney 
Local Health District, Sydney, Australia. We included patients older than 18 years, with 
documented CHD who were able to provide informed consent. CHD was defined as documented 
myocardial infarction, coronary artery bypass graft surgery, or percutaneous coronary 
intervention, or proven angiographically and documented before consent. Patients were excluded 
if they did not have an active mobile phone, sufficient English language proficiency to read text 
messages, or were referred for evaluation of congenital heart disease or coronary anomalies. 
Ethical approval was obtained from the Western Sydney Local Health Network Human Research 
Ethics Committee. Figure 1 displays the study flow chart. A total of 1301 patients with CHD were 
invited to participate, 591 did not meet all inclusion criteria or declined to participate and 710 
were randomized in TEXT ME. 19 Twenty-seven participants (including 12 who were unable to be 
contacted, 5 who died and 10 with missing data for depression symptoms at 6 months) were 
excluded from the analysis. Therefore, the current analyses were performed on 683 participants 
(96%).    
Patient involvement: No patients were involved in the design of the study, recruitment and 
conduct of the study. However, during the process evaluation we shared the results of the study 
with the participants and collected feedback from the participants. The process evaluation focus 
group discussions took place after participants completed the intervention and follow-up visit.    
 
Randomization, trial procedure and intervention: Randomization was performed using a 
computerized randomization program through a secure web interface. The random allocation 
sequence was in a uniform 1:1 allocation ratio with a block size of 8 and was concealed from 
study personnel. After recruitment and discharge from hospital, if they were hospitalised, patients 
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would receive a text message informing them of their allocation.. Data were collected during face-
to-face interviews using a structured questionnaire at baseline and 6 months by trained research 
assistants at the outpatient Cardiology clinic of Westmead Hospital. At study entry all intervention 
participants were provided brief training on how to read, delete and save the text messages. Data 
entry was performed by study staff through entering data into the secure web interface. The web-
based computer program was set to send messages to patients randomized to the intervention. The 
message program development was based on behaviour change techniques linked to the 
theoretical framework reported by Abraham and Michie.20,21 In brief, it involved regular semi-
personalised text messages providing advice, motivation, and information that aimed to improve 
general heart health, diet, physical activity and encourage smoking cessation (where relevant).22 
Participants randomised to the intervention group received 4 text-messages per week for 24 
weeks. Participants received minimum information on depressive symptoms being common in 
patients with CHD, and were advised to seek further help when needed, which is aligned with the 
curriculum of secondary prevention. For example, participants were encouraged to seek additional 
support “Not having support of family and friends can worsen heart disease- if you need help, 
don’t be afraid to ask”. The design, development and samples of the text messages for TEXT ME 
have been described in a separate paper.22 Examples of text messages used in the TEXT ME are 
provided in Supplementary Table S1.  
 
Variables and outcomes: Data were collected on demographics, medical history and disease 
factors, including age, sex, years of education, current smoking and drinking status, history of 
diabetes, history of hypertension and history of depression. The history of depression included 
questions on prior treatment with medicines, counselling or electroconvulsive therapy (ECT). 
Physical activity was assessed with the Global Physical Activity Questionnaire.23 Anthropometric 
measurements of weight, height, waist circumference and blood pressure were measured 
according to standardized procedures at baseline and at 6 months. Health-related quality of life 
was assessed using the SF-12 questionnaire at baseline and 6 months. 24  
 
Depressive symptoms were assessed at 6 months using the 9-item Patient Health Questionnaire 
(PHQ-9). The questionnaire was only administered at the follow-up visit as there were concerns 
that assessment at baseline while in hospital was not a true reflection of baseline, and that 
repeating this questionnaire at two-time points may impact responses. The PHQ-9 is a depression 
screening tool which generates a total score from 0-27. Scores are categorized as 0-4 no 
depression, 5-9 mild depression,10-14 moderate depression, 15-19 moderately severe depression, 
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and 20-27 severe depression.25 The PHQ-9 has been shown to have reasonable sensitivity (81.5) 
and specificity (80.6) at cut-off score ≥5 for patients with CHD 25 and has been widely used to 
detect depression symptoms in clinical settings.26-28 The PHQ-9 has showed good reliability 
(Cronbach's α 0.89 and 0.86) and validity with similar tools to screen depression (i.e PHQ-9 was 
found to be highly correlated with scores on the Beck Depression Inventory in the general 
population, r=0.73). 
 
Data analysis: Analyses were conducted on data using IBM SPSS version 20.0 (IBM 
Corporation, USA) and SAS version 9.0 (SAS Institute Inc, Cary, North Carolina, USA). The 
primary endpoint was the difference in PHQ-9 scores between intervention and control groups at 
6 months. Baseline variables were summarised as frequency data, means and standard deviations 
(SD).  The Shapiro-Wilk test of normality was used to evaluate distribution of the PHQ-9 scores. 
The mean difference in intervention and control group depression scores at 6 months were 
compared using an independent t-test, and between depression severity categories by Fisher’s 
exact tests. The relative risks were reported with 95% confidence intervals (CIs) for group 
differences and in people with a history of depression. We conducted a post-hoc analysis with 
PHQ-9 scores dichotomised at ≥ 5 representing mild symptoms of depression or greater. For the 
subgroup analysis, we performed a log binomial model for the binary outcome (depressed/not 
depressed, where depressed is any score of PHQ-9 ≥5) with treatment, subgroup and treatment by 
subgroup interaction as fixed effects. No baseline or any other covariates were included. All tests 
were two-sided and statistical significance was set at 0.05. 
 
 
Results 
There were no significant differences in the baseline characteristics of the 683 participants 
included in the analyses and the 27 who were excluded (Figure 1).   
 
The mean age of participants was 58±9 years, 18% were women. 16% had a history of depression 
of whom 60% reported prior treatment with counselling, 25% medication and 3% 
electroconvulsive therapy (ECT). Almost two-thirds of the participants (62%) had history of 
hypertension and one-third (32%) a history of diabetes. Baseline characteristics were similar 
between the randomised groups (Table 1).  
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Effects of text messaging on depression: Depression scores at 6 months were significantly lower 
(better) in the intervention group compared to the control group, with a mean difference of 1.9 
(95% CI 1.5 to 2.4, p-value <0.0001) on the PHQ-9. The difference between the different categories of 
depression symptoms (mild, moderate, moderately severe and severe depression) reported by the 
participants was significantly lower in the intervention group compared to the control group (p<0.001).The 
frequency of mild to moderate depressive symptoms (PHQ-9 scores5-14) at 6 months was 6% in 
the intervention and 25% in the control group, (Relative Risk 0.26, 95% CI 0.16 to 0.40, p <0.001, 
unadjusted). The number of participants reporting any depression (PHQ-9 ≥5) was significantly 
higher in the control group compared to the intervention group (86 vs 21). (Table 2) 
 
Table 3. reports the difference in the distribution of the PHQ-9 items at 6 months between the 
intervention and control groups. The differences were significantly different between groups for 
PHQ-9 item 1-7 at 6 months and fairly consistent across all items. The frequency of participants 
endorsing PHQ-9 item 9 relating to suicidality was 0.6% in the intervention group vs 0.9% in the 
control group (RR 0.70, 95% CI 0.12 to 4.17, p=0.696). (Table 3)  
Figure 2 reports the treatment effect on PHQ-9 scores at 6 months by patient subgroup. The 
relative risk of being depressed after treatment compared to not being treated was consistent 
across patient sub-groups: age, sex, education, BMI, physical activity, current smoking, current 
drinking, and history of depression, diabetes, and hypertension (Figure 2 and Supplementary 
Table S2). The mental health component score of the SF-12 was significantly lower in the 
intervention group compared to the control group at 6 months (Supplementary Table S3). The 
rates of PHQ-9 ≥5 among people with a history of depression were 4/44 (9.1%) vs 29/62 (46.8%) 
in intervention vs control (RR 0.19, 95% CI 0.07 to 0.51, p<0.001), and were 17/289 (5.9%) vs 
57/288 (19.8%) among others (RR 0.30, 95% CI 0.18 to 0.50, p<0.001). 
 
Discussion  
In the TEXT ME trial, we found that a lifestyle-focused cardiovascular secondary prevention 
program delivered via text-message, and not specifically targeting depression or other abnormal 
mood symptoms, resulted in fewer symptoms of depression at 6 months in participants receiving 
the texting intervention. There were 75% fewer patients reporting PHQ-9 scores over 5 in the 
intervention groups and this proportional reduction was similar across different patient groups and 
somewhat unexpected given the lack of therapeutic content provided in the intervention. This size 
of difference is consistent with one depressive symptom that occurred nearly every day now only 
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occurring several days a week, or reducing from more than half the days of the week to not at all; 
or alternatively the cessation of two symptoms that previously occurred several days a week. 
 
A recent systematic review assessing the impact of text messaging interventions in individuals 
with mental health disorders suggested that the interventions might be effective in improving 
mental health outcomes.17  However, the evidence for mHealth interventions in lowering 
depressive symptoms in CHD patients, or in patients with other chronic health conditions is 
limited. The Care Assessment Platform for Cardiac Rehabilitation (CAP-CR) 29 smart-phone 
based intervention conducted in 120 post-myocardial infarction patients, in 2009, included a 
comprehensive package of health and exercise monitoring, motivational and educational material 
delivery via text messaging, and weekly mentoring consultations. It demonstrated reductions in 
psychological distress at six-weeks (measured by Kessler 10 Psychological Distress Scale 30 K10, 
mean difference 1.85, 95% CI -0.11 to 3.8, p=0.1 and DASS-depression score, mean difference 
0.90, 95%CI −0.77 to 2.57, p=0.3). Attendance in cardiac rehabilitation programs have been 
shown to be associated with decreased symptoms of depression, and improved psychological 
well-being.31 Internet-based cognitive behavioural therapy support programs have also been 
shown to have potential in reducing depressive symptoms .32 33 With increasing use of mobile 
phones, text messaging has the potential to support cardiac rehabilitation and reduce the burden of 
cardiovascular diseases and depression.34  
 
In addition to the main effects on clinical outcomes of TEXT ME,19 the additional benefit of 
TEXT ME in reducing depressive symptoms at 6 months make it a very appealing low-cost 
strategy for patients with CHD. Depression is associated with worse health outcomes in patients 
with CHD.35 36 Poor health behaviours, such as smoking, non-adherence to prescribed medications 
and lifestyle changes are observed in patients with depression.37 Previous studies have suggested 
association of depression with quality of life 38. In our trial, quality of life- mental component 
summary scores were significantly lower in the intervention group compared to control group. 
These results should be interpreted cautiously because medication use can be a marker of 
depression, and our trial did not collect information on dose and duration of medication use for 
depression. It is possible that the improvements in behavioural risk factors in TEXT ME may have 
been in-part mediated by improvements in psychological well-being. From our qualitative 
evaluation,21 participants in TEXT ME felt supported and engaged, and this is likely to contribute 
to the mechanisms that explain the reduction in depressive symptoms. It is also possible that the 
focus on improving lifestyle behaviours in TEXT ME contributed to the fewer  depressive 
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symptoms as maintaining a healthy lifestyle is a key component of many depression management 
programs.39  
 
The strengths of this trial is the parallel group, prospective, randomized controlled design and a 
relatively large sample size. With respect to limitations, it is a single-centre study, and the 
findings need to be replicated in other centres and populations. The analysis is a sub-study and 
secondary analysis of the main TEXT ME trial and baseline measures of PHQ-9 were not 
included. The PHQ-9 was designed as a screening tool for depression and depressive symptoms. 
We did not confirm the presence of depression in trial participants using the gold standard semi-
structured psychiatric interview. However, self-reported depression scores are highly correlated 
with the diagnosis of clinical depression and the PHQ-9 ≥5 cut point has good sensitivity (82%) 
and specificity (81%) when used with CHD patients.26 While we did not assess depressive 
symptoms at baseline, randomization ensured that most patient characteristics were distributed 
evenly between groups.  
 
A previous study in Denmark, of 19, 520 acute coronary syndrome patients reported the 
prevalence of depression 15 – 20%. .40  A meta-analysis in patients with heart disease reported 
that, the risk of mortality was two times higher in people with a history of depression.38 Our trial 
showed that the prevalence of depressive symptoms was lower in the intervention group compared 
to control group among those with a history of depression. While depression is recognised as 
important to manage in patients with chronic disease, there are few mechanisms available to help 
prevent the development of depression in patients at risk. The findings of this study indicate 
exciting potential of a simple and potentially scalable text-message based intervention to support 
mild to moderate depressive symptoms in this population. Addressing depressive symptoms early 
may be key to supporting patients in achieving multiple lifestyle risk factor behavioural change.  
 
In summary, this study demonstrates that provision of a text-messaged based intervention focused 
on lifestyle change among people with CHD was associated with fewer symptoms of milf to 
moderate depression at 6 months in the intervention group compared to controls. These results 
suggest that text messaging might be a low-cost and scalable intervention to address the 
development of depression in patients with cardiovascular diseases. Further research is needed to 
determine whether  a text-messaging program can prevent the development of depression in 
patients with CHD. 
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Panel: Research in context 
Systematic review 
Systematic reviews of randomized controlled studies of mobile phone technologies for 
health behaviour change and diseases management suggest that text messaging interventions 
might be useful for self-management of chronic diseases.11 Another systematic review of 
seven studies measuring the impact of text messaging in mental health reported that five 
studies had significant improvements in a variety of psychiatric and social functioning 
assessments.17 These studies suggest mobile phone text messaging program has potential to 
support management of patients with mental illness. 
 
Interpretation 
The results of the TEXT ME trial suggest that provision of a text-messaged based intervention 
focused on lifestyle change among people with coronary heart disease was associated with 
less mild to moderate depressive symptoms at 6 months. These results suggest that text 
messaging might be a low-cost and scalable intervention to address the development of 
depression in patients with cardiovascular diseases.  
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Figure legends: 
Figure 1. Flow Chart 
Figure 2. Treatment effects on PHQ-9 scores ≥5 at 6 months, by patient subgroup  
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Table 1. Baseline characteristics of the study participants 
Characteristics 
  
Intervention Group 
(n=333) 
n (%) 
Control Group 
(n=350) 
n (%) 
Age, mean (SD) years 57.9 (9.0) 57.3 (9.2) 
Women  61 (18.3) 61 (17.4) 
Education, mean (SD), years 11.4 (3.5) 11.5 (3.5) 
Body Mass Index, BMI, kg/m2 mean (SD) 29.7 (6.0) 29.6 (5.9) 
Physical activity- regular exercise  32 (9.6) 35 (10.0) 
Current drinker  86 (25.8) 116 (33.1) 
Current smoker  174 (52.3) 189 (54.0) 
History of diabetes  105 (31.5) 114 (32.6) 
History of hypertension  212 (63.7) 212 (60.6) 
History of depression 44 (13.2) 62 (17.7) 
 Prior medication  14/44 (31.8) 13/62 (21.0) 
 Prior psychological counselling  25/44 (56.8) 41/62 (66.1) 
 Prior electroconvulsive therapy 3/44 (6.8) 0/62 (0.0) 
SD Standard deviation;  
 
 
Table 2. Depression scores (PHQ-9) at 6 months  
Variables Intervention 
(N=333) 
n (%) 
Control 
(N=350) 
n (%) 
Mean Difference 
(95% CI) 
P-value 
PHQ-9 total score, mean (SD) 1.0 (2.2) 2.9 (3.3) 1.9 (1.5 to 2.4) <0.0001* 
No depression [score 0-4] 312 (93.7) 264 (75.4)   
Mild depression [score 5-9] 16 (4.8) 68 (19.4)   
Moderate depression [score 10-14] 4 (1.2) 16 (4.6)   
Moderately severe [score 15-19] 1 (0.3) 1 (0.3)   
Severe depression [score 20-27]  0 (0) 1 (0.3)   
Any depression [score 5-27] 21 (6.3) 86 (24.6)  <0.001^ 
SD Standard Deviation; * Independent t-test; ^ Fisher’s Exact test 
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Table 3. Difference in PHQ-9 items at 6 months  
Variables Intervention 
(N=333) 
n (%) 
Control 
(N=350) 
n (%) 
P-value 
PHQ-9 item 1: Little interest or pleasure in doing things 26 (7.8) 85 (24.3) <0.001 
PHQ-9 item 2: Feeling down, depressed or hopeless 43 (12.9) 132 (37.7) <0.001 
PHQ-9 item 3: Trouble falling or staying asleep, or sleeping 
too much 
44 (13.2) 119 (34.0) <0.001 
PHQ-9 item 4: Feeling tired or having little energy 67 (20.1) 187 (53.4) <0.001 
PHQ-9 item 5: Poor appetite or overeating 25 (7.5) 60 (17.1) <0.001 
PHQ-9 item 6: Feeling bad about yourself — or that you are 
a failure or have let yourself or your family down 
17 (5.1) 35 (10.0) 0.016 
PHQ-9 item 7: Trouble concentrating on things, such as 
reading the newspaper or watching television 
10 (3.0) 23 (6.6) 0.030 
PHQ-9 item 8: Moving or speaking so slowly that other 
people could have noticed? Or so fidgety or restless that 
you have been moving a lot more than usual 
4 (1.2) 8 (2.3)  0.281 
PHQ-9 item 9: Thoughts that you would be better off dead, 
or thoughts of hurting yourself in some way 
2 (0.6) 3 (0.9) 0.694 
PHQ-9 item 9 relating to suicidality 
 
 
